Introducing Glatopa—a synthetic polypeptide formulation of glatiramer acetate developed to the Copaxone standard. This injectable therapy modulates the immune system by mimicking myelin basic protein, reducing relapse frequency and stabilizing neurological function in multiple sclerosis. Experience improved disease control and enhanced quality of life with this advanced, targeted therapy delivered via a prefilled syringe.